EverPrime vs SkinnyRx
SkinnyRx has an open FDA warning letter dated February 20, 2026. EverPrime has none. No price lines up like for like. They share compounded semaglutide injection, but SkinnyRx's $99 is a first-month price.
To see where both sit among the other sellers, read our best weight-loss injection providers board.
The record
EverPrime / SkinnyRx
EverPrime
7.5/10
Featured pick (affiliate partner)
SkinnyRx
6.3/10
- Rite-Away Pharmacy503A
- Vios Compounding Pharmacy503A
- TruMedsRx503A
- and 2 more
SkinnyRx is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. EverPrime pays us nothing. The scores are computed the same way for both and are shown as computed (EverPrime 7.5, SkinnyRx 6.3). How we are paid
What the record shows
- 01
SkinnyRx has an open FDA warning letter dated February 20, 2026. EverPrime has none.
- 02
EverPrime names five pharmacies. SkinnyRx names no compounding pharmacy in our record.
- 03
No price lines up like for like. They share compounded semaglutide injection, but SkinnyRx's $99 is a first-month price.
- 04
Only SkinnyRx lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and compounded oral semaglutide.
- 05
SkinnyRx covers seven states EverPrime does not.
Prices and terms, product by product
A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.
EverPrime
SkinnyRx
$249/mo
$3,237 a year, 13 charges
$99/mo
first month only; not compared
$169/mo
$2,028 a year
$99/mo
first month only; not compared
$1,400/mo
$16,800 a year
$1,400/mo
$16,800 a year
$149/mo
first month only; not compared
$199/mo
first month only; not compared
$248/mo
$2,976 a year
$248/mo
$2,976 a year
Read off each seller’s own pages. EverPrime: October 27, 2026. SkinnyRx: October 30, 2026. Every plan and dose we hold is on the full review.
The case for each
The case for EverPrime
7.5/10- No FDA warning letter on record
- Names its compounding pharmacy
The case for SkinnyRx
6.3/10- Sells brand-name semaglutide pen and brand-name tirzepatide pen, which EverPrime does not price
- Lists 47 states against 40
- Open FDA warning letter, February 20, 2026
- Names no compounding pharmacy
Scores
EverPrime 7.5 · SkinnyRx 6.3 out of 10. Six weighted parts.
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
The score is the same formula for every seller. Payment does not enter it. Method
EverPrime vs SkinnyRx: questions
Other sellers we are paid by
Affiliate partners outside this pair. Each has its own record and review, scored the same way.
- Eden8.7
From $99/mo
Visit site - YourEra9.0
From $99/mo
Visit site - bmiMD8.2
From $129/mo prepaid
Visit site
Sellers closest to these two
- EverPrime vs Gala
- EverPrime vs Direct Meds
- EverPrime vs Embody
- EverPrime vs CoreAge Rx
- SkinnyRx vs Found
- SkinnyRx vs ShedRx
Matched on molecule, form and price. Every pair we list · The register
Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks